Cue Biopharma Inc reports results for the quarter ended in March - Earnings Summary

Cue Biopharma

11/05/2021 08:45

* Cue Biopharma Inc  CUE.OQ  reported a quarterly adjusted loss
of 41 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 38 cents per share.
* Revenue rose 72.6% to $1.55 million from a year ago​; 
analysts expected $585.60 thousand.
* Cue Biopharma Inc's reported EPS for the quarter was a loss
of 41 cents​.
* The mean earnings estimate of analysts had risen by about 6.3%
in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Cue Biopharma Inc shares had risen by 17.9% this quarter and
gained 14.9% so far this year.
* The company reported a quarterly loss of $12.51 million.
* Wall Street's median 12-month price target for Cue Biopharma
Inc is $30.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 07:45 a.m. GMT.
​All figures in $